XETRA : BNN.DE

BRAIN Biotech AG

$2.78 EUR

$0 (0.0%)

Volume
2.14K
Average Volume
6.24K
Market Capitalization
$60.74M
P/E Ratio
-5.27
Dividend Yield
0.00%
Price Target
Year High
$3.89
Year Low
$1.95
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.44
Company Overview

XETRA

Adriaan Moelker

Biotechnology

Healthcare

BNN.DE

280

DE

EUR

https://www.brain-biotech.com

49 62 51 9331 0

D1R155106

N/A

Liquidity Metrics

-1.24

1.44

0.87

0.27

0.00

Sales & Valuation

$49.62M

0.99

-15.69

-6.75

-0.41

Profitability

-$0.54

-$11.74M

-18.98%

-18.51%

-1361.43%

-18.56%

P/E Metrics

-5.27

-0.40

-0.40

Analyst Price Target & Rating

Sell

2/5

0 Analysts

%

Financial Health Scores

-1.54

4/9

$6.86M

$62.66M

$66.53M

-$8.84M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Martin Langer MD & Executive Vice President
Alexander Pelzer Vice President and Head of Research & Development - Zwingenberg
Jurgen Eck Consultant
Ute Dechert Vice President of Human Resources & Processes
Adriaan Moelker Chairman of the Management Board & Chief Executive Officer
Johan Jansen-Storbacka Executive Vice President of BRAIN Biocatalysts enzyme products business
Michael Schneiders Chief Financial Officer & Member of Management Board
Robbert Michael Hoekstra Head of Group Finance
Ulrich Putsch Co-Founder
Poll Results

No votes yet today — be the first to share your view!

About BRAIN Biotech AG (XETRA:BNN.DE) Stock

Headquartered in Zwingenberg, Germany, and founded in 1993, BRAIN Biotech AG (renamed from B.R.A.I.N. Biotechnology Research and Information Network AG in April 2021) specializes in the discovery, development, production, and commercialization of advanced biological solutions. These include enzymes, biocatalysts, microorganisms, and naturally derived active compounds, catering to the chemical industry across Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two distinct segments: BioScience and BioIndustrial. The BioScience division is dedicated to uncovering and developing bioactive natural ingredients, such as sugar alternatives, taste modifiers, and other nature-based active components for diverse applications in the food, animal n ... utrition, skincare, cosmetics, and broader chemical sectors. Concurrently, the BioIndustrial segment focuses on identifying and optimizing enzymes and biocatalysts critical for manufacturing food and beverages, medical wound care products, lubricants, as well as for starch processing and bioethanol production. This segment also engineers microorganisms to serve as functional biomass for optimizing industrial manufacturing processes, converting greenhouse gas CO2 into a valuable industrial raw material, and facilitating the extraction of precious and rare earth metals. Furthermore, BRAIN Biotech AG has established strategic alliances with AnalytiCon Discovery GmbH and Roquette to jointly develop natural sweeteners and enhanced sweet taste solutions.

Frequently Asked Questions

What is the current BRAIN Biotech AG (BNN.DE) stock price?

BRAIN Biotech AG(XETRA:BNN.DE) stock price is $2.78 in the last trading session. During the trading session, BNN.DE stock reached the peak price of $3.89 while $1.95 was the lowest point it dropped to. The percentage change in BNN.DE stock occurred in the recent session was 0.0% while the dollar amount for the price change in BNN.DE stock was $0.

BNN.DE's industry and sector of operation?

The XETRA listed BNN.DE is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of BNN.DE?

Martin Langer | MD & Executive Vice President
Alexander Pelzer | Vice President and Head of Research & Development - Zwingenberg
Jurgen Eck | Consultant
Ute Dechert | Vice President of Human Resources & Processes
Adriaan Moelker | Chairman of the Management Board & Chief Executive Officer

How many employees does BNN.DE have?

Number of BNN.DE employees currently stands at 280. BNN.DE operates from Darmstädter Strasse 34-36, Zwingenberg, HE 64673, DE.

Link for BNN.DE official website?

Official Website of BNN.DE is: https://www.brain-biotech.com

How do I contact BNN.DE?

BNN.DE could be contacted at phone #49 62 51 9331 0 and can also be accessed through its website. BNN.DE operates from Darmstädter Strasse 34-36, Zwingenberg, HE 64673, DE.

How many shares of BNN.DE are traded daily?

The average number of BNN.DE shares traded daily for last 3 months was 6.24K.

What is the market cap of BNN.DE currently?

The market value of BNN.DE currently stands at $60.74M with its latest stock price at $2.78